| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.77B | +3.3% |
| Cost of Revenue | $2.10B | +1.7% |
| R&D Expense | $112.7M | +10.6% |
| SG&A Expense | $887.8M | +2.6% |
| Operating Income | $780.7M | +10.2% |
| Interest Expense | $102.0M | +9.6% |
| Pre-tax Income | $698.8M | +13.2% |
| Income Tax | $101.3M | +32.2% |
| Net Income | $597.5M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $503.8M | +7.6% |
| Inventory | $423.0M | -3.5% |
| Current Assets | $1.42B | +4.5% |
| Total Assets | $4.49B | +4.1% |
| Current Liabilities | $696.9M | -35.5% |
| Long-term Debt | $2.00B | -0.8% |
| Total Liabilities | $2.99B | -0.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $675.0M | +12.4% |
| Capital Expenditures | $92.1M | +9.4% |
| Investing Cash Flow | -$228.4M | -76.9% |
| Financing Cash Flow | -$394.5M | -32.1% |
| Free Cash Flow | $582.9M | +12.9% |
| +10.6% |
| EPS (Basic) | $6.85 | +11.4% |
| EPS (Diluted) | $6.82 | +11.4% |
| Stockholders' Equity |
| $1.50B |
| +13.8% |